Sunho Biologics (02898) Announces Monthly Return for January 2026
Bulletin Express
Feb 04
Sunho Biologics, Inc. (02898) disclosed its monthly return as of January 31, 2026. The announcement shows that the authorized share capital remains unchanged at 200,000,000 ordinary shares, with a par value of USD 0.0005 each, totaling USD 100,000. The issued share capital also remains at 156,666,800 shares, with no treasury shares held.
According to the disclosure, the company’s public float meets the applicable threshold requirement. There are no reported changes regarding share options, warrants, convertibles, or any other agreements to issue additional shares during the reporting period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.